Information about Equipharma
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0475.932.379

VAT liability
Yes
Established
25-09-2001
Last balance sheet year
2025
Company size
Micro 0 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Equipharma

2025 2024 2023 2022
Profit/Loss 82,111 131 % -262,349 -1151 % 24,952 90 % 13,133
Equity -75,256 52 % -157,367 -250 % 104,982 14 % 92,030
Gross margin 85,141 95 % 43,760 -24 % 57,672 33 % 43,207

Publications from Equipharma

Date Publication
22-06-2023 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Resignations - Appointments - General meeting (NL)
23-12-2005 Registered Office Relocation (NL)
08-06-2002 Resignation(s) Appointment(s) Modification Designation Registered Office Relocation (NL)
06-11-2001 Constitution (NL)

Frequently asked questions

What is the VAT number of Equipharma?
The VAT number of Equipharma is BE 0475.932.379.
Wat is the PEPPOL ID of Equipharma?
The PEPPOL ID of Equipharma is 0208:0475932379. Log in or start a free trial to see the full overview.
When was Equipharma founded?
Equipharma was founded on 25-09-2001.
What is the address of Equipharma?
The current registered office of Equipharma is located at Mechelsestraat 17, 1800 Vilvoorde.
When was the last time Equipharma filed their annual financial statements?
The most recent financial statements of Equipharma were filed on 21-03-2026.
How many employees does Equipharma have?
There are currently no employees working at Equipharma or no workforce information is available.
What is the annual turnover of Equipharma?
At the time of its most recent financial statements, Equipharma did not publish any turnover figures. Equipharma reported a gross margin of €85,140.70.